Company / Depreciation & Amortization
Solventum Depreciation & Amortization History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$489.0M
FY2025
5-year range
$489.0M / $578.0M
FY2022-FY2025
Trend
-11.9%
vs FY2024
Sector context
#25 of 142
Health Care
What the data says
Solventum's depreciation & amortization of $489M is higher than 82% of companies in the Health Care sector (FY2025). Depreciation & Amortization has declined for 3 consecutive years, from $578M in FY2022 to $489M in FY2025.
Based on SEC 10-K filings.
$489M in FY2025 with a 3-year CAGR of -5.4%. Top quartile in the Health Care sector.
Improved from $561M to $489M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -5.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
+40.7% above sector average
Key checks
Key Insights
- Solventum's depreciation & amortization has declined for 3 consecutive years.
- 3-year CAGR of -5.4%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 11.9% year-over-year.
- Ranks #25 out of 142 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 30.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $489.0M | -11.9% |
| FY2024 | $555.0M | -1.1% |
| FY2023 | $561.0M | -2.9% |
| FY2022 | $578.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026